DDInter219 DDInter1625
A complex of related glycopeptide antibiotics from <i>Streptomyces verticillus</i> consisting of bleomycin A2 and B2 (B2 CAS # 9060-10-0). It inhibits DNA metabolism and is used as an antineoplastic, especially for solid tumors. Bleomycin A2 is used as the representative structure for Bleomycin.
Rubella virus vaccine is a live attenuated virus vaccine for active immunization against rubella (German measles) that is subcutaneously administered. It is prepared from RA 27/3 strain of live attenuated rubella virus. Rubella is a common childhood disease, caused by rubella virus (togavirus).
Bleomycin {u} (Compound) treats {v} (Disease) melanoma
Bleomycin {u} (Compound) binds {v} (Gene) BLMH
Bleomycin {u} (Compound) causes {v} (Side Effect) Hypomagnesaemia
Bleomycin {u} may cause a minor interaction that can limit clinical effects when taken with {v} Cinoxacin
Bleomycin {u} may cause a minor interaction that can limit clinical effects when taken with {v} Moxifloxacin
Bleomycin {u} may cause a moderate interaction that could exacerbate diseases when taken with {v} Alefacept
Bleomycin {u} may cause a moderate interaction that could exacerbate diseases when taken with {v} Clofarabine
Bleomycin {u} may lead to a major life threatening interaction when taken with {v} Golimumab
Bleomycin {u} may lead to a major life threatening interaction when taken with {v} Natalizumab
Bleomycin (Compound) treats melanoma (Disease)
Bleomycin (Compound) binds BLMH (Gene)
Bleomycin (Compound) causes Hypomagnesaemia (Side Effect)
Bleomycin may cause a minor interaction that can limit clinical effects when taken with Cinoxacin
Bleomycin may cause a minor interaction that can limit clinical effects when taken with Moxifloxacin
Bleomycin may cause a moderate interaction that could exacerbate diseases when taken with Alefacept
Bleomycin may cause a moderate interaction that could exacerbate diseases when taken with Clofarabine
Bleomycin may lead to a major life threatening interaction when taken with Golimumab
Bleomycin may lead to a major life threatening interaction when taken with Natalizumab